Keyphrases
Pro-apoptotic
77%
Small Molecule Activation
77%
Cancer Therapy
77%
Trigger Zone
68%
BAX Activation
66%
Cancer Cells
57%
Cancer Cell Death
41%
Anti-apoptotic
33%
Apoptosis
31%
Acute Myeloid Leukemia
27%
BH3-only Proteins
27%
Tumorigenesis
22%
Bcl-2 Family Proteins
20%
B-cell Lymphoma 2 (Bcl-2)
20%
Mitochondrial Apoptotic Pathway
18%
In Cancer
18%
Pharmacological Properties
16%
Cell Death
16%
Small Molecules
16%
Pharmacological Strategies
16%
Direct Activation
16%
Therapeutic Strategies
16%
Cancer Cell Biology
13%
Lead Structure
13%
Cell Death Regulation
13%
Synthetic Chemistry
13%
High Profile
13%
Point of No Return
13%
Apoptotic Resistance
13%
In Vivo Toxicity Study
13%
Mitochondrial Apoptosis
12%
Overexpression
11%
Novel Leads
11%
Apoptosis Regulators
11%
In Vivo Efficacy
11%
Therapeutic Efficacy
11%
Acute Myeloid Leukemia Cells
11%
Small Molecule Therapeutics
11%
Mitochondria
11%
Chemoresistance
11%
Therapeutic Approaches
11%
Chemotherapy-induced
11%
Multidisciplinary Approach
11%
Outer Mitochondrial Membrane
11%
Structural Biology
11%
Biochemical Studies
11%
Permeabilization
11%
Cell Life
11%
Binding Studies
11%
Xenograft
11%
Activation Mechanism
11%
Critical Friend
11%
Life-and-death
11%
Genetic Modification
11%
Translocated
11%
Cancer Therapeutics
11%
Target Validation
11%
Mechanism of Action
11%
Tumor
11%
Apoptotic Pathway
9%
Venetoclax
7%
Safety Properties
7%
Oral Pharmacokinetics
7%
Safety Potential
7%
In Vitro ADME
7%
ADME-Tox Properties
7%
Combination Treatment
7%
Medicinal Chemistry
5%
Anti-apoptotic Proteins
5%
Promote Apoptosis
5%
Bcl-xL
5%
In Vitro Activity
5%
Current Treatment
5%
Tumor Growth
5%
Cell Properties
5%
Novel Mechanism
5%
Growth Maintenance
5%
Tumor Maintenance
5%
Expression Level
5%
FDA-approved Drugs
5%
Leukemia
5%
Drug-resistant Tumor
5%
Apoptotic Activity
5%
Selective Inhibitor
5%
Therapeutic Potential
5%
Pharmacokinetic Properties
5%
Apoptosis Regulation
5%
Clinical Application
5%
Effector Proteins
5%
Structural Insights
5%
Myeloid Cell leukemia-1 (Mcl-1)
5%
Cancer Model
5%
Oral Bioavailability
5%
Innovative Therapies
5%
Tumor Resistance
5%
Specific Intent
5%
Cancer Hallmarks
5%
Growth Resistance
5%
Novel Biomarkers
5%
2nd Generation
5%
Solid Tumor Cell Lines
5%
Molecular Insight
5%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Antiapoptotic
32%
BH3 Protein
31%
Acute Myeloid Leukemia
26%
Neoplasm
20%
Pharmacokinetics
13%
Carcinogenesis
12%
Venetoclax
8%
Combination Therapy
7%
Drug Resistance
6%
Tumor Resistance
6%
Leukemia
6%
Cancer Model
6%
Tumor Growth
6%
Biological Marker
6%
Pharmaceutical Chemistry
6%
Absorption Distribution Metabolism Excretion
6%
Bioavailability
6%
Solid Malignant Neoplasm
6%
Lead Compound
5%
Efficacy Study
5%
Chemotherapy
5%
Biochemistry, Genetics and Molecular Biology
Small Molecule
66%
Cancer Cell
66%
Cell Death
35%
Myeloid
25%
Carcinogenesis
15%
Drug Resistance
8%
Protein Family
8%
Biochemistry
8%
Mitochondrion
6%
Efficacy Study
6%
Outer Mitochondrial Membrane
6%